Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2026-07-14 @ 4:00 AM
Study NCT ID:
NCT01847235
Status:
COMPLETED
Last Update Posted:
2016-04-26
First Post:
2013-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
Sponsor:
Seoul National University Hospital
Organization: